Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin

被引:84
作者
Mahabusarakam, W
Proudfoot, J
Taylor, W
Croft, K
机构
[1] Univ Western Australia, Dept Med, Perth, WA 6847, Australia
[2] Prince Songkla Univ, Dept Chem, Hat Yai, Thailand
[3] Univ Sydney, Dept Chem, Sydney, NSW 2006, Australia
关键词
D O I
10.1080/10715760000301161
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative damage is thought to play a critical role in cardiovascular and other chronic diseases. This has led to considerable interest in the antioxidant activity of dietary compounds. Flavonoids have received the most attention and much is known about the structural requirements for antioxidant activity. However, little is known about the antioxidant activity of other plant derived phenolic compounds such as the xanthones. We have previously shown that the prenylated xanthone, mangostin, can inhibit the oxidation of low density lipoprotein. In order to examine the effects of structure modification on antioxidant activity of this class of compound we have prepared a number of derivatives of mangostin and tested antioxidant activity in an isolated LDL and plasma assay. The results of this study show that structural modification of mangostin can have a profound effect on antioxidant activity. Derivatisation of the C-3 and C-6 hydroxyl groups with either methyl, acetate, propane diol or nitrile substantially reduces antioxidant activity. In contrast, derivatisation of C-3 and C-6 with aminoethyl derivatives enhanced antioxidant activity, which may be related to changes in solubility. Cyclisation of the prenyl chains had little influence on antioxidant activity.
引用
收藏
页码:643 / 659
页数:17
相关论文
共 29 条
[1]   Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system [J].
Arora, A ;
Nair, MG ;
Strasburg, GM .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 24 (09) :1355-1363
[2]   The role of oxidized lipoproteins in atherogenesis [J].
Berliner, JA ;
Heinecke, JW .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (05) :707-727
[3]  
Brown JE, 1998, BIOCHEM J, V330, P1173
[4]   Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships [J].
Cao, GH ;
Sofic, E ;
Prior, RL .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (05) :749-760
[5]   Histaminergic and serotonergic receptor blocking substances from the medicinal plant Garcinia mangostana [J].
Chairungsrilerd, N ;
Furukawa, KI ;
Ohta, T ;
Nozoe, S ;
Ohizumi, Y .
PLANTA MEDICA, 1996, 62 (05) :471-472
[6]   Mangostanol, a prenyl xanthone from Garcinia mangostana [J].
Chairungsrilerd, N ;
Takeuchi, K ;
Ohizumi, Y ;
Nozoe, S ;
Ohta, T .
PHYTOCHEMISTRY, 1996, 43 (05) :1099-1102
[7]   Antioxidant activity of natural flavonoids is governed by number and location of their aromatic hydroxyl groups [J].
Chen, ZY ;
Chan, PT ;
Ho, KY ;
Fung, KP ;
Wang, J .
CHEMISTRY AND PHYSICS OF LIPIDS, 1996, 79 (02) :157-163
[8]   The chemistry and biological effects of flavonoids and phenolic acids [J].
Croft, KD .
TOWARDS PROLONGATION OF THE HEALTHY LIFE SPAN: PRACTICAL APPROACHES TO INTERVENTION, 1998, 854 :435-442
[9]  
CROFT KD, 1991, EICOSANOIDS, V4, P75
[10]   LOW-DENSITY-LIPOPROTEIN COMPOSITION AND OXIDIZABILITY IN CORONARY-DISEASE - APPARENT FAVORABLE EFFECT OF BETA-BLOCKERS [J].
CROFT, KD ;
DIMMITT, SB ;
MOULTON, C ;
BEILIN, LJ .
ATHEROSCLEROSIS, 1992, 97 (2-3) :123-130